We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
New mRNA technology could make jabs better-matched to different annual strains and improve efficacy
French pharma group has two candidates in pipeline
Resources and trial data will be shared with governments and each other
Post-Brexit registrations could be ‘five months faster’, says medicines regulator
Twenty years after autism was falsely linked to vaccines, anxiety is still high
Drugmaker plans to submit 9 drugs to regulators over next 18 months
French drugmaker teams up with US biotech group Berg to develop improved vaccines
French pharma group boosted by consumer healthcare, vaccines and genzyme divisions
Expansion of immunisation programmes in developing countries lifts market
New approaches to fight virus strains are under trial, as virologists say another pandemic is inevitable
International health body backs use of new drug in countries with high rates of virus
One million Filipino school children to be given shots costing €20 apiece
Commitment comes after WHO declares virus a global public health emergency
French drugmaker bypasses US and European regulators to take product directly to affected countries
Pharma group looks to tap rising healthcare spending as analysts forecast revenues of €1bn a year
International Edition
